Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics-Reference-Cited by-同舟云学术

Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics

Published:2008 Issue:1 Volume:10 Page:69-82
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Campioni D.,Lanza F.,Moretti S.,Ferrari L.,Cuneo A.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference41 articles.

1. Clarification of the nomenclature of MSC: the International Society for Cellular Therapy position statement;Horwitz;Cytotherapy,2005

2. Stem cell alchemy;Orkin;Nat Med,2000

3. Somatic stem cell plasticity: current evidence and emerging concepts;Wulf;Exp Hematol,2001

4. Multilineage potential of adult human mesenchymal stem cells;Pittenger;Science,2000

5. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells;Reyes;Blood,2001

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration;Pharmaceuticals;2024-03-07

2. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08

3. The skeletal stem cell;Marcus and Feldman's Osteoporosis;2021

4. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression;PLOS ONE;2019-11-20

5. A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cells;Cytotherapy;2019-02